Skip to main content
Premium Trial:

Request an Annual Quote

'Superbug' Molecular Test From Mobidiag Gets CE Mark

NEW YORK (GenomeWeb) — Finnish diagnostics firm Mobidiag said today that it received CE-IVD marking for its Novodiag CarbaR+ test for carbapenemase-producing enterobacteriaceae (CPE), a bacteria resistant to carbapenem antibiotics.

The multiplex qPCR- and microarray-based test detects CPE and associated resistance markers, as well as a plasmid-mediated resistance for colistin, a last-resort antibiotic for many infections. It runs on the company's automated Novodiag system and produces results within 80 minutes.

Mobidiag currently offers two other CE-marked antibiotic resistance screening tests including CarbaR+VRE and CarbaR+MCR, which run on the firm's Amplidiag multiplex system.

"With our Amplidiag and Novodiag tests, we offer comprehensive diagnostic solutions to a wide range of infectious diseases in both centralized and decentralized laboratories, regardless of their size and patient volumes," Mobidiag CEO Tuomas Tenkanen said in a statement.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.